Werewolf Therapeutics (HOWL) News Today → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free HOWL Stock Alerts $4.85 -0.08 (-1.62%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 9, 2024 | americanbankingnews.comWerewolf Therapeutics, Inc. (NASDAQ:HOWL) to Post Q2 2024 Earnings of ($0.40) Per Share, HC Wainwright ForecastsMay 8, 2024 | markets.businessinsider.comWerewolf Therapeutics: Buy Rating Affirmed Amid Promising Clinical Advancements and Pipeline PotentialMay 8, 2024 | americanbankingnews.comWerewolf Therapeutics (NASDAQ:HOWL) Stock Rating Reaffirmed by JMP SecuritiesMay 8, 2024 | americanbankingnews.comWedbush Reiterates Outperform Rating for Werewolf Therapeutics (NASDAQ:HOWL)May 8, 2024 | americanbankingnews.comWerewolf Therapeutics (NASDAQ:HOWL) Stock Rating Reaffirmed by HC WainwrightMay 6, 2024 | markets.businessinsider.comThe Analyst Verdict: Werewolf Therapeutics In The Eyes Of 4 ExpertsMay 6, 2024 | marketbeat.comWerewolf Therapeutics (NASDAQ:HOWL) Earns "Outperform" Rating from WedbushWedbush restated an "outperform" rating and issued a $9.00 target price on shares of Werewolf Therapeutics in a research report on Monday.May 6, 2024 | markets.businessinsider.comBuy Rating Affirmed for Werewolf Therapeutics Amid Promising Financials and Anticipated Clinical UpdatesMay 3, 2024 | investorplace.comHOWL Stock Earnings: Werewolf Therapeutics Misses EPS, Misses Revenue for Q1 2024May 3, 2024 | yahoo.comHowl: Leonardo DiCaprio Working on Live-Action Movie Told From a Dog and Wolf’s PerspectiveMay 3, 2024 | globenewswire.comWerewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 2, 2024 | yahoo.comMy patient thinks he’s a werewolf: 10 years as an NHS psychiatristMay 1, 2024 | msn.comHowling Deal: Great Wolf Lodge offers $84 specialApril 30, 2024 | msn.comWhy Do Dogs Howl? 6 Top Reasons Your Dog HowlsApril 24, 2024 | globenewswire.comWerewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingApril 23, 2024 | finance.yahoo.comWerewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual MeetingApril 23, 2024 | globenewswire.comWerewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual MeetingApril 19, 2024 | markets.businessinsider.comBuy Rating Affirmed for Werewolf Therapeutics on Promising PREDATOR Platform Prospects and Strong Pipeline PotentialApril 15, 2024 | marketbeat.comShort Interest in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Grows By 9.3%Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) was the target of a significant increase in short interest in March. As of March 31st, there was short interest totalling 472,000 shares, an increase of 9.3% from the March 15th total of 432,000 shares. Currently, 1.6% of the shares of the stock are sold short. Based on an average daily trading volume, of 240,200 shares, the days-to-cover ratio is currently 2.0 days.April 12, 2024 | msn.comWhy Howl's turn-based tactics are ideal for mobileApril 5, 2024 | globenewswire.comWerewolf Therapeutics Presents Preclinical Results Demonstrating Anti-Tumor Effects of Pro-Inflammatory Cytokine Therapeutics WTX-518 and WTX-712 at AACR 2024 Annual MeetingApril 4, 2024 | seekingalpha.comWerewolf Therapeutics: In The Hunt For Success In The Cytokine SpaceApril 4, 2024 | globenewswire.comWerewolf Therapeutics to Present First-of-Its-Kind Data Demonstrating Utility for PREDATOR™ Platform in Immunology-Based Diseases at AAI Annual MeetingApril 3, 2024 | marketbeat.comWerewolf Therapeutics (NASDAQ:HOWL) Now Covered by Analysts at JMP SecuritiesJMP Securities started coverage on Werewolf Therapeutics in a research report on Wednesday. They issued a "market outperform" rating and a $12.00 target price on the stock.March 21, 2024 | marketbeat.comWerewolf Therapeutics (NASDAQ:HOWL) Trading 2.9% Higher Werewolf Therapeutics (NASDAQ:HOWL) Trading 2.9% HigherMarch 15, 2024 | morningstar.comWerewolf Therapeutics Inc HOWLMarch 11, 2024 | markets.businessinsider.comBuy Rating Affirmed for Werewolf Therapeutics with Anticipated Surge on WTX-124 Phase 1 Data ReleaseMarch 9, 2024 | finance.yahoo.comWerewolf Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues LagMarch 7, 2024 | markets.businessinsider.comBuy Rating Reiterated for Werewolf Therapeutics Amid Promising INDUKINE Platform DevelopmentsMarch 7, 2024 | investorplace.comHOWL Stock Earnings: Werewolf Therapeutics Beats EPS, Misses Revenue for Q4 2023March 7, 2024 | benzinga.comRecap: Werewolf Therapeutics Q4 EarningsMarch 7, 2024 | finanznachrichten.deWerewolf Therapeutics, Inc.: Werewolf Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateMarch 7, 2024 | globenewswire.comWerewolf Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateMarch 6, 2024 | finance.yahoo.comHOWL Mar 2024 2.500 putMarch 6, 2024 | globenewswire.comWerewolf Therapeutics to Present at the 2024 Leerink Partners Global Biopharma ConferenceMarch 5, 2024 | globenewswire.comWerewolf Therapeutics Announces Upcoming Presentations at AACR Annual Meeting 2024February 27, 2024 | finance.yahoo.comWerewolf Therapeutics, Inc. (HOWL)February 21, 2024 | benzinga.comWerewolf Therapeutics Stock (NASDAQ:HOWL), Short Interest ReportFebruary 20, 2024 | yahoo.comDo wolf reintroduction programs restore ecosystems? It's not that simple, researchers sayFebruary 20, 2024 | yahoo.comCool Video Captures Rare Sight of Wolf Pack Trekking Through Deep Snow in ChinaFebruary 12, 2024 | msn.comWolves howl in different accentsFebruary 10, 2024 | msn.comWerewolf Therapeutics Expands Offering with $25M Stock SaleFebruary 8, 2024 | yahoo.comWatch mesmerizing footage of gray wolf running in the snow captured by Colorado rancherFebruary 6, 2024 | marketbeat.comHC Wainwright Weighs in on Werewolf Therapeutics, Inc.'s FY2028 Earnings (NASDAQ:HOWL)Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Free Report) - Equities researchers at HC Wainwright issued their FY2028 EPS estimates for Werewolf Therapeutics in a note issued to investors on Monday, February 5th. HC Wainwright analyst A. Maldonado expects that the company will post earnings per shaJanuary 24, 2024 | news.yahoo.comThe Wolf Moon will howl at five planets above Boise this week. Here’s how to view them allJanuary 19, 2024 | msn.comHowl review - If you go into the woods todayJanuary 17, 2024 | msn.comMesmerizing Video Captures Harmonious Howls of Wolf Pack Serenading in the SnowJanuary 8, 2024 | finanznachrichten.deWerewolf Therapeutics, Inc.: Werewolf Therapeutics Provides Business Update and Highlights 2024 Strategic OutlookJanuary 8, 2024 | finance.yahoo.comWerewolf Therapeutics Provides Business Update and Highlights 2024 Strategic OutlookJanuary 5, 2024 | finanznachrichten.deWerewolf Therapeutics, Inc.: Werewolf Therapeutics Appoints Michael Atkins, M.D., to its Board of Directors Get Werewolf Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HOWL and its competitors with MarketBeat's FREE daily newsletter. Email Address Wall Street legend who predicted 2021 tech crash issues new warning (Ad)People around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history. Watch his stock warning right here, 100% free of charge HOWL Media Mentions By Week HOWL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HOWL News Sentiment▼0.140.54▲Average Medical News Sentiment HOWL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HOWL Articles This Week▼31▲HOWL Articles Average Week Get Werewolf Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HOWL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Aldeyra Therapeutics News 2seventy bio News 23andMe News Foghorn Therapeutics News Immutep News Veru News Pyxis Oncology News Conduit Pharmaceuticals News AC Immune News Emergent BioSolutions News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HOWL) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressWall Street legend who predicted 2021 tech crash issues new warningChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 AI Stocks to Buy for 2024Market Moving TrendsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop 5 Tech Stocks to Buy for 2024Daily Market AlertsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Werewolf Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
